Tenapanor in Synucleinopathy-Related Constipation

• Status: RECRUITING
• Trial end date: 2027-03-01

Summary

Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation

• Phase: PHASE2

Details

• Lead Sponsor: Cedar Valley Digestive Health Center
• Collaborator: Ardelyx
• Treatments: tenapanor